Milestone Pharmaceuticals
MIST
MIST
85 hedge funds and large institutions have $35.6M invested in Milestone Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
5.78% less ownership
Funds ownership: 31.11% → 25.32% (-5.8%)
33% less capital invested
Capital invested by funds: $53.6M → $35.6M (-$17.9M)
41% less call options, than puts
Call options by funds: $426K | Put options by funds: $718K
Holders
85
Holding in Top 10
2
Calls
$426K
Puts
$718K
Top Buyers
| 1 | +$6.7M | |
| 2 | +$3.5M | |
| 3 | +$2M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.49M |
| 5 |
Two Sigma Investments
New York
|
+$1.41M |
Top Sellers
| 1 | -$5.68M | |
| 2 | -$1.75M | |
| 3 | -$1.63M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.34M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$455K |
